Keynote Address: On Target: Neural Mechanisms of Therapeutic Change

Only available as part of a package

Join our featured keynote lecture by Dr. Ajilore on mechanisms of change in integrative treatments for multimorbid conditions, namely depression and obesity, through the ENGAGE and ENGAGE-2 studies. He will also share findings from a novel voice-enabled AI-based therapy coach to deliver problem solving therapy for individuals with mild to moderate depression and/or anxiety.

This session offers 1 CE credit.

Olu Ajilore, M.D., Ph.D.

University of Illinois-Chicago

Dr. Ajilore is the Center for Depression and Resilience Professor in the Department of Psychiatry at the University of Illinois-Chicago. He graduated magna cum laude from Harvard University with a degree in biology. Dr. Ajilore did his MD/PhD degree at Stanford University where he studied the negative effects of stress hormones on the brain. His lab currently uses computational neuroimaging techniques and digital biomarkers to better track and treat neuropsychiatric disorders. Dr. Ajilore is also serves as the Associate Head for Faculty Development, the director the Mood and Anxiety Disorders Program and as a member of the National Advisory Mental Health Council for NIMH.

On Target: Neural Mechanisms of Therapeutic Change

This talk will review the use of problem-solving treatment and for multimorbid conditions, namely depression and obesity exploring the findings from the mechanistic ENGAGE and ENGAGE-2 studies. Then we will discuss how these findings informed the development of a voice-enabled, AI-based therapy coach to deliver PST for participants with mild-to-moderate depression and/or anxiety. Finally, the promise and peril of using AI therapy chatbots will be discussed with a review of evaluation frameworks for digital therapeutics.

Category: Translational, Neuroscience / Neuroimaging, Treatment - Other

Keyword: Translational Research, Neuroscience, Treatment

All levels of familiarity with the material

Participants earn 1 continuing education credit

Outline:

Introduction to problem-solving therapy
- ENGAGE study findings - efficacy and mechanisms
- ENGAGE-2 study findings - efficacy and mechanisms
Introduction to voice-enabled, AI-based therapy coach to deliver problem-solving therapy
- Intervention development
- RCT findings
Discussion of AI therapy chatbots
- Advantages, challenges, and ethical considerations for use of AI therapy chatbots
- Review of evaluation frameworks for digital therapeutics

At the end of this session, the learner will be able to:

Describe therapeutic mechanism(s) of problem-solving therapy for multimorbid conditions, specifically depression and obesity.
Describe the development and efficacy of a voice-enabled, AI-based therapy coach for problem-solving therapy in depression and anxiety.
Evaluate potential advantages and drawbacks of using AI-based therapy coaches for mental health care.

1-2 Long Term Goals for the Attendee (takeaways)

Develop a foundational understanding of neural circuits that may be associated with cognitive-behavioral therapies.
Develop a foundational understanding of the use of AI in mental health treatment, including opportunities for enhancing treatment, related challenges, and ethical considerations.

Recommended Readings:

Lv, N., Ajilore, O. A., Xiao, L., Venditti, E. M., Lavori, P. W., Gerber, B. S., ... & Ma, J. (2023). Mediating effects of neural targets on depression, weight, and anxiety outcomes of an integrated collaborative care intervention: the engage-2 mechanistic pilot randomized clinical trial. Biological Psychiatry Global Open Science, 3(3), 430-442.
Kannampallil, T., Ajilore, O. A., Lv, N., Smyth, J. M., Wittels, N. E., Ronneberg, C. R., ... & Ma, J. (2023). Effects of a virtual voice-based coach delivering problem-solving treatment on emotional distress and brain function: a pilot RCT in depression and anxiety. Translational psychiatry, 13(1), 166.
Obradovich, N., Khalsa, S. S., Khan, W. U., Suh, J., Perlis, R. H., Ajilore, O., & Paulus, M. P. (2024). Opportunities and risks of large language models in psychiatry. NPP—Digital Psychiatry and Neuroscience, 2(1), 8.

This session offers 1 CE credit. All attendees will receive a certificate of completion when the course requirements are satisfied. Certificates of completion is included in the cost of the summit

ABCT is approved by the American Psychological Association to sponsor continuing education for psychologists. ABCT maintains responsibility for this program and its content

The Association for Behavioral and Cognitive Therapies has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5797. Programs that do not qualify for NBCC credit are clearly identified. The Association for Behavioral and Cognitive Therapies is solely responsible for all aspects of the programs

The Association for Behavioral and Cognitive Therapies is recognized by the California Board of Behavioral Sciences for Marriage and Family Therapist (MFT) to offer continuing education as Provider #4600

Association for Behavioral and Cognitive Therapies (ABCT), is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0124

Association for Behavioral and Cognitive Therapies (ABCT), is recognized by the New York State Education Department’s State Board for Social Workers as an approved provider of continuing education for licensed social workers #SW-0657

Key:

Complete

Failed

Available

Locked

Keynote Address: On Target: Neural Mechanisms of Therapeutic Change

06/07/2024 at 1:30 PM (EDT) | Recorded On: 06/11/2024 | 60 minutes

You must register to access.

Quiz

10 Questions | 2 attempts | 8/10 points to pass

You must register to access.

Session Evaluation

7 Questions

You must register to access.

New York State Psychologist Certificate